Jolita Satkus, MD | |
2801 W Kinnickinnic River Pkwy Ste 260, Milwaukee, WI 53215 | |
(414) 649-6780 | |
(414) 649-3763 |
Full Name | Jolita Satkus |
---|---|
Gender | Female |
Speciality | Endocrinology |
Experience | 29 Years |
Location | 2801 W Kinnickinnic River Pkwy Ste 260, Milwaukee, Wisconsin |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205028487 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Aurora St Lukes Medical Center | Milwaukee, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity or chemistry, and then treat behavior problems by selectively stimulating relevant brain circuits.
"If the United States does not follow through on global health commitments, there could be a reversal or stagnation of recent gains in reducing maternal deaths and incidences of tuberculosis, malaria, HIV and other diseases in developing countries, warns a report published [Monday]," titled "Global Health: Investing in Our Future," an InterAction press release states.
News outlets report on some of the lesser-known provisions of the health care bills pending in Congress, including possible improvements for the Indian Health System and mandated calorie count labels on vending machines.
Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit.
› Verified 4 days ago
Entity Name | Aurora Medical Group, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity or chemistry, and then treat behavior problems by selectively stimulating relevant brain circuits.
"If the United States does not follow through on global health commitments, there could be a reversal or stagnation of recent gains in reducing maternal deaths and incidences of tuberculosis, malaria, HIV and other diseases in developing countries, warns a report published [Monday]," titled "Global Health: Investing in Our Future," an InterAction press release states.
News outlets report on some of the lesser-known provisions of the health care bills pending in Congress, including possible improvements for the Indian Health System and mandated calorie count labels on vending machines.
Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Jolita Satkus, MD 2801 W Kinnickinnic River Pkwy Ste 260, Milwaukee, WI 53215-3631 Ph: (414) 649-6780 | Jolita Satkus, MD 2801 W Kinnickinnic River Pkwy Ste 260, Milwaukee, WI 53215 Ph: (414) 649-6780 |
News Archive
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity or chemistry, and then treat behavior problems by selectively stimulating relevant brain circuits.
"If the United States does not follow through on global health commitments, there could be a reversal or stagnation of recent gains in reducing maternal deaths and incidences of tuberculosis, malaria, HIV and other diseases in developing countries, warns a report published [Monday]," titled "Global Health: Investing in Our Future," an InterAction press release states.
News outlets report on some of the lesser-known provisions of the health care bills pending in Congress, including possible improvements for the Indian Health System and mandated calorie count labels on vending machines.
Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit.
› Verified 4 days ago
Julia Bonner, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3351 North Downer Avenue, Milwaukee, WI 53211 Phone: 414-229-5684 | |
Dr. Zachary Smith, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-6830 Fax: 414-955-6214 | |
Dr. Christopher Patrick Boyd, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6000 Fax: 414-805-6280 | |
Umair Bajwa, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-0812 Fax: 414-805-0855 | |
Rasika Surajyam Chepuri, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-7040 Fax: 414-955-6211 | |
Soryal A Soryal, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1020 N 12th St, 3rd Floor, Milwaukee, WI 53233 Phone: 414-219-7300 | |
Aboud Affi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1218 W Kilbourn Ave, Suite 404, Milwaukee, WI 53233 Phone: 414-291-3100 |